Key result
Withholding sirolimus with dietary and insulin management cuts severe hypertriglyceridemia by ~80% in an infant.
Why the study?
Mesenteric lymphatic malformations are rare congenital anomalies that may involve extensive visceral structures and present significant therapeutic challenges, especially when complicated by recurrent intra-abdominal disease and severe hypertriglyceridemia in infancy.
Case Report (n=1)
No
This case report demonstrates that severe sirolimus-associated hypertriglyceridemia in an infant with congenital mesenteric lymphatic malformation can be effectively managed by withholding sirolimus alongside insulin infusion, bowel rest, and low-fat MCT-based nutrition, underscoring the need for longitudinal metabolic monitoring.
Answers are grounded in this paper and cite their sources.
May warrant lipid monitoring with sirolimus for mesenteric LM in infancy; hypothesis-generating for management of this rare complication.
Background and Clinical Significance: Mesenteric lymphatic malformations (LMs) are rare congenital anomalies that may involve extensive visceral structures and present significant therapeutic challenges. We report an unusual case of congenital mesenteric LM complicated by recurrent intra-abdominal disease and severe hypertriglyceridemia during infancy. Case Presentation: A female infant with an antenatally diagnosed mesenteric LM underwent surgical excision on the second day of life, with histopathology confirming cystic lymphangioma. Despite surgery and treatment with sirolimus and propranolol, further intra-abdominal cystic lesions were identified. At 10 months, intestinal obstruction required repeat laparotomy, revealing milky peritoneal fluid suggestive of chylous leakage. During a January 2026 admission at 14 months of age, following a recent viral infection (varicella/influenza A), severe hypertriglyceridemia (990 mg/dL) was documented, and sirolimus was withheld following recognition of dyslipidemia because of its known lipid-related adverse effects. Temporary bowel rest, intravenous hydration, a short insulin infusion, and low-fat MCT-based nutritional management were followed by declining triglycerides—391 mg/dL on day 9 and 192 mg/dL on day 15. Conclusions: This case highlights the challenges of managing extensive mesenteric LM and sirolimus-associated hypertriglyceridemia, potentially accompanied by additional precipitating factors. The response cannot be attributed to a single intervention; careful longitudinal metabolic and nutritional monitoring is essential.
No takes yet. Share an insight, caveat, or question.
Spoială et al. (2026) conducted a case report in Congenital mesenteric lymphatic malformation with severe hypertriglyceridemia (n=1). Sirolimus withholding, temporary bowel rest, IV hydration, short insulin infusion, and low-fat MCT-based nutrition was evaluated on Serum triglyceride levels. Withholding sirolimus alongside bowel rest, insulin infusion, and MCT-based nutrition reduced severe hypertriglyceridemia from /dL to /dL on day 9 and /dL on day 15.
Synapse has enriched 10 related papers. Consider them for comparative context: